Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896778 · ClinicalTrials.gov registry record · NA
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01896778 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 9 participants.
The verdict
NCT01896778, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer. Heating tumor cells to several degrees above normal body temperature may kill tumor cells.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Hyperthermia Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-10-04 |
| Est. Completion | 2018-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01896778
The ClinicalTrials.gov registry entry for NCT01896778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01896778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01896778 about?
NCT01896778 is a clinical study titled "Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer". This randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer. Heating tumor cells to several degrees above normal body temperature may kill tumor cells.
What is the current status of trial NCT01896778?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-10-04. Estimated completion is 2018-02-23.
What interventions are being tested in trial NCT01896778?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Hyperthermia Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01896778?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.